NZ337888A - Use of eprosartan to treat isolated systolic hypertension - Google Patents
Use of eprosartan to treat isolated systolic hypertensionInfo
- Publication number
- NZ337888A NZ337888A NZ337888A NZ33788898A NZ337888A NZ 337888 A NZ337888 A NZ 337888A NZ 337888 A NZ337888 A NZ 337888A NZ 33788898 A NZ33788898 A NZ 33788898A NZ 337888 A NZ337888 A NZ 337888A
- Authority
- NZ
- New Zealand
- Prior art keywords
- eprosartan
- systolic hypertension
- isolated systolic
- hypertension
- pressor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4780097P | 1997-05-27 | 1997-05-27 | |
| PCT/US1998/010794 WO1998053816A1 (en) | 1997-05-27 | 1998-05-27 | Method of treating isolated systolic hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ337888A true NZ337888A (en) | 2001-04-27 |
Family
ID=21951046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ337888A NZ337888A (en) | 1997-05-27 | 1998-05-27 | Use of eprosartan to treat isolated systolic hypertension |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20020040045A1 (pt) |
| EP (1) | EP1003506B1 (pt) |
| JP (1) | JP2002500673A (pt) |
| KR (1) | KR20010013014A (pt) |
| CN (1) | CN1257427A (pt) |
| AR (1) | AR012872A1 (pt) |
| AT (1) | ATE307580T1 (pt) |
| AU (1) | AU740646B2 (pt) |
| BR (1) | BR9809611A (pt) |
| CA (1) | CA2288722C (pt) |
| CZ (1) | CZ298390B6 (pt) |
| DE (1) | DE69832075T2 (pt) |
| ES (1) | ES2251083T3 (pt) |
| HU (1) | HUP0003249A3 (pt) |
| IL (1) | IL132154A (pt) |
| MX (1) | MXPA99010970A (pt) |
| NO (1) | NO326141B1 (pt) |
| NZ (1) | NZ337888A (pt) |
| PL (1) | PL191971B1 (pt) |
| SA (1) | SA98190174B1 (pt) |
| TR (1) | TR199902914T2 (pt) |
| TW (1) | TW579296B (pt) |
| WO (1) | WO1998053816A1 (pt) |
| ZA (1) | ZA984421B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006076097A2 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US544080A (en) * | 1895-08-06 | Centrifugal filtering-machine | ||
| US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| JPH05199342A (ja) * | 1991-05-20 | 1993-08-06 | Xerox Corp | 無声の手書きによる携帯式通信装置および方法 |
-
1998
- 1998-05-25 ZA ZA984421A patent/ZA984421B/xx unknown
- 1998-05-27 HU HU0003249A patent/HUP0003249A3/hu unknown
- 1998-05-27 DE DE69832075T patent/DE69832075T2/de not_active Expired - Lifetime
- 1998-05-27 AU AU76017/98A patent/AU740646B2/en not_active Ceased
- 1998-05-27 AT AT98923815T patent/ATE307580T1/de not_active IP Right Cessation
- 1998-05-27 KR KR1019997010988A patent/KR20010013014A/ko not_active Application Discontinuation
- 1998-05-27 CZ CZ0420099A patent/CZ298390B6/cs not_active IP Right Cessation
- 1998-05-27 CN CN98805305A patent/CN1257427A/zh active Pending
- 1998-05-27 JP JP50086599A patent/JP2002500673A/ja active Pending
- 1998-05-27 BR BR9809611-7A patent/BR9809611A/pt not_active Application Discontinuation
- 1998-05-27 MX MXPA99010970A patent/MXPA99010970A/es not_active IP Right Cessation
- 1998-05-27 TW TW087108204A patent/TW579296B/zh not_active IP Right Cessation
- 1998-05-27 WO PCT/US1998/010794 patent/WO1998053816A1/en active IP Right Grant
- 1998-05-27 TR TR1999/02914T patent/TR199902914T2/xx unknown
- 1998-05-27 EP EP98923815A patent/EP1003506B1/en not_active Expired - Lifetime
- 1998-05-27 AR ARP980102464A patent/AR012872A1/es not_active Application Discontinuation
- 1998-05-27 ES ES98923815T patent/ES2251083T3/es not_active Expired - Lifetime
- 1998-05-27 PL PL336886A patent/PL191971B1/pl not_active IP Right Cessation
- 1998-05-27 CA CA002288722A patent/CA2288722C/en not_active Expired - Fee Related
- 1998-05-27 IL IL13215498A patent/IL132154A/en not_active IP Right Cessation
- 1998-05-27 NZ NZ337888A patent/NZ337888A/en unknown
- 1998-06-17 SA SA98190174A patent/SA98190174B1/ar unknown
-
1999
- 1999-11-26 NO NO19995797A patent/NO326141B1/no not_active IP Right Cessation
-
2001
- 2001-10-24 US US09/999,808 patent/US20020040045A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1003506B1 (en) | 2005-10-26 |
| CA2288722C (en) | 2007-04-24 |
| CN1257427A (zh) | 2000-06-21 |
| CZ298390B6 (cs) | 2007-09-19 |
| AU740646B2 (en) | 2001-11-08 |
| AU7601798A (en) | 1998-12-30 |
| BR9809611A (pt) | 2000-07-04 |
| IL132154A (en) | 2002-12-01 |
| US20020040045A1 (en) | 2002-04-04 |
| NO995797L (no) | 1999-11-26 |
| CZ420099A3 (cs) | 2000-09-13 |
| CA2288722A1 (en) | 1998-12-03 |
| TW579296B (en) | 2004-03-11 |
| NO995797D0 (no) | 1999-11-26 |
| HUP0003249A3 (en) | 2002-02-28 |
| ZA984421B (en) | 1998-11-27 |
| WO1998053816A1 (en) | 1998-12-03 |
| SA98190174B1 (ar) | 2006-05-13 |
| NO326141B1 (no) | 2008-10-06 |
| DE69832075D1 (de) | 2005-12-01 |
| PL191971B1 (pl) | 2006-07-31 |
| DE69832075T2 (de) | 2006-07-13 |
| IL132154A0 (en) | 2001-03-19 |
| KR20010013014A (ko) | 2001-02-26 |
| ES2251083T3 (es) | 2006-04-16 |
| ATE307580T1 (de) | 2005-11-15 |
| AR012872A1 (es) | 2000-11-22 |
| MXPA99010970A (es) | 2005-07-25 |
| PL336886A1 (en) | 2000-07-17 |
| HUP0003249A2 (hu) | 2002-01-28 |
| TR199902914T2 (xx) | 2000-06-21 |
| EP1003506A1 (en) | 2000-05-31 |
| JP2002500673A (ja) | 2002-01-08 |
| EP1003506A4 (en) | 2000-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA00002784A (es) | Sistema basado en modelo estadistco multivariado pra verificar la operacion de un fundidor continuo y detectar la aparicion de rebabas por rotura de molde inminentes. | |
| JP2004503588A (ja) | 全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−２阻害薬および血管調節化合物 | |
| JPH11228410A (ja) | イミダゾールアンジオテンシン−ｉｉ受容体拮抗薬からなる慢性腎不全治療剤 | |
| HU219404B (hu) | Eljárás kardiális és vaszkuláris hipertrófia és/vagy hiperplazia kezelésére alkalmas angiotenzin-II-receptor blokkoló hatású vegyületet tartalmazó gyógyszerkészítmények előállítására | |
| JPH07504659A (ja) | Ａｃｅ阻害剤及び利尿剤の併用 | |
| EP0561977B1 (en) | Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke | |
| WO1993020816A1 (en) | Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy | |
| EP0660713B1 (en) | Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy | |
| WO1994018958A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
| KR20090094288A (ko) | 고형 제제 | |
| CA2288722C (en) | Method of treating isolated systolic hypertension | |
| RU2182002C2 (ru) | Композиция с фиксированной дозой ингибитора ангиотензин-превращающего фермента и антагониста кальциевых каналов, способ ее изготовления и применение для лечения сердечно-сосудистых заболеваний | |
| JP2005506369A (ja) | 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用 | |
| US20010005723A1 (en) | Method of treating isolated systolic hypertension | |
| US20030045561A1 (en) | Method of treating isolated systolic hypertension | |
| JPH0532635A (ja) | ヒスタミン誘導体の治療への応用と、新規なヒスタミン誘導体と、この誘導体の医薬としての使用 | |
| EP3900722A1 (en) | Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases | |
| AU7559501A (en) | Method of treating isolated systolic hypertension | |
| CA1110170A (en) | Antihypertensive compositions | |
| US4189492A (en) | Antihypertensive compositions of 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxy-ethyl)benzenemethanamine | |
| JPH04279524A (ja) | 脳血管疾患治療剤 | |
| KR100222627B1 (ko) | 앙기오텐신-ii 수용체 길항제 및 칼슘 채널 차단제의 신규한 조성물 | |
| Weber | Prolonged calcium channel blocker therapy of hypertension | |
| CA2498049A1 (en) | At<sb>1</sb> receptor antagonists for preventing secondary strokes | |
| JPH0648961A (ja) | 医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |